Mutations

British coronavirus variant may soon become predominant in the US by March. Florida being hit hard.

Mon, 2021-02-08 01:19 — mike kraft

A more contagious variant of the coronavirus first found in Britain is spreading rapidly in the United States, doubling roughly every 10 days, according to a new study.

Analyzing half a million coronavirus tests and hundreds of genomes, a team of researchers predicted that in a month this variant could become predominant in the United States, potentially bringing a surge of new cases and increased risk of death.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about British coronavirus variant may soon become predominant in the US by March. Florida being hit hard.
Log in or register to post comments

TheHill.com AstraZeneca vaccine works against UK coronavirus variant: study

Sat, 2021-02-06 00:36 — mike kraft

AstraZeneca vaccine works against UK coronavirus variant: study The AstraZeneca-Oxford COVID-19 vaccine protects against a more transmissible variant of the virus first identified in the United Kingdom, according to research published Friday. Peter Sullivan TheHill

The AstraZeneca-Oxford COVID-19 vaccine protects against a more transmissible variant of the virus first identified in the United Kingdom, according to research published Friday.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about TheHill.com AstraZeneca vaccine works against UK coronavirus variant: study
Log in or register to post comments

UK backs CureVac effort to make vaccine for COVID variants U.S. rushes to catch up

Fri, 2021-02-05 23:15 — mike kraft

UK backs CureVac effort to make vaccine for COVID variants LONDON (AP) — The U.K. government announced Friday that it plans to work with a German biopharmaceutical company to develop vaccines targeting emerging variants of COVID-19 as public health... AP NEWS

LONDON (AP) — The U.K. government announced Friday that it plans to work with a German biopharmaceutical company to develop vaccines targeting emerging variants of COVID-19 as public health officials call for new tools to keep the virus in check as it mutates.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about UK backs CureVac effort to make vaccine for COVID variants U.S. rushes to catch up
Log in or register to post comments

U.S. FDA gearing up for rapid review of potential COVID-19 booster shots

Fri, 2021-02-05 22:55 — mike kraft

U.S. FDA gearing up for rapid review of potential COVID-19 booster shots The U.S. Food and Drug Administration is planning a rapid review process for quick turnaround of new COVID-19 booster shots if variants of the coronavirus emerge against which the vaccines do not provide protection, the agency's top official said on Thursday. Reuters Staff U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. FDA gearing up for rapid review of potential COVID-19 booster shots
Log in or register to post comments

Worrisome coronavirus mutation seen in U.K. variant and in some U.S. samples

Wed, 2021-02-03 23:26 — mike kraft

Worrisome coronavirus mutation seen in U.K. variant and in some U.S. samples In experiments and clinical trials, mutation appears to limit the effectiveness of vaccines. Joel Achenbach, William Booth Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Worrisome coronavirus mutation seen in U.K. variant and in some U.S. samples
Log in or register to post comments

Oxford finds COVID-19 shot 76% effective for 3 months after single dose

Wed, 2021-02-03 03:18 — mike kraft

Oxford finds COVID-19 shot 76% effective for 3 months after single dose Oxford University and AstraZeneca's COVID-19 vaccine showed in a study it had 76% efficacy against symptomatic infection for three months after a single dose, which increased if the second shot is delayed, backing Britain's vaccine rollout policy. Alistair Smout U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Oxford finds COVID-19 shot 76% effective for 3 months after single dose
Log in or register to post comments

Small study suggests Pfizer's COVID-19 vaccine less effective against South African variant

Wed, 2021-02-03 03:07 — mike kraft

Study suggests Pfizer's COVID-19 vaccine less effective against South African variant The Pfizer-BioNTech COVID-19 vaccine may be less able to protect against infection with a South African variant of the virus that has a worrying mutation, according to results of a British study released on Tuesday. Kate Kelland U.S.

LONDON (Reuters) - The Pfizer-BioNTech COVID-19 vaccine may be less able to protect against infection with a South African variant of the virus that has a worrying mutation, according to results of a British study released on Tuesday.

Country / Region Tags:

General Topic Tags: